What is CVE-2026-1025?

CVE-2026-1025 is a medium-severity vulnerability in IBM Common Licensing, classified under Cross-site Scripting. CVSS score: 6.1/10. Published 2026-09-18.

How severe is CVE-2026-1025?

Medium severity. CVSS v3 base score is 6.1 out of 10.

XSS in IBM Common Licensing

CVE-2026-1025

IBM Common Licensing Agent 9.0, Agent 9.0.0.1, Agent 9.0.0.2, ART 9.0, ART 9.0.0.1, and ART 9.0.0.2 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.

Vulnerability class: XSS (Cross-Site Scripting)

CVSS v3 metric

CVSS v3 base score 6.1 (Medium). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N.

Affected products

Ibm Common Licensing — versions ART 9.0, ART 9.0.0.1, ART 9.0.0.2

Weakness classification (CWE)

CWE-79 — Cross-site Scripting

References

psirt@us.ibm.com (vendor-advisory, patch)

Frequently asked questions

What is CVE-2026-1025?: CVE-2026-1025 is a medium-severity vulnerability in IBM Common Licensing, classified under Cross-site Scripting. CVSS score: 6.1/10. Published 2026-09-18.
How severe is CVE-2026-1025?: Medium severity. CVSS v3 base score is 6.1 out of 10.